News | April 19, 2007

Interventional Cardiology Device Market Climbs From Late-’06 Dip

April 20, 2007 — The U.S. interventional cardiology market value increased 1.5 percent in Q1 2007 over Q4 2006, according to Millennium Research Group's (MRG) Marketrack service.

Coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloons, intravascular ultrasound (IVUS) catheters, thrombectomy devices and atheterectomy devices all grew in market value after a slow December in 2006.

"In December we saw percutaneous coronary intervention (PCI) procedures and revenues on the decline, but it seems that this past quarter has shown an increase," say Bina Mistry, analyst at MRG. "Risks associating drug coated stents with late stent thrombosis slowed down procedure volumes in December. In Q1 2007, however, PCI procedures increased with less hesitation by physicians to perform this treatment option. Moreover, an increase in PTCA balloon, thrombectomy, and atherectomy procedures was also noticed - such procedures can replace stent procedures in patients suffering from coronary artery disease (CAD).

Additionally, screening initiatives through diagnostic angiographies has increased in Q1 2007 over Q1 2006. As a result, diagnostic catheters, which facilitate the diagnosis of CAD during this procedure, experienced increased unit sales translating into a market increase of 47 percent in Q1 2007 compared to Q1 2006.

Interventional Cardiology Marketrack gathers data from over 140 cath labs throughout the US on a monthly basis. Product categories covered include drug-eluting coronary stents, bare-metal coronary stents, PTCA balloons, guide wires, guiding catheters, diagnostic catheters, embolic protection devices, IVUS catheters, introducer sheaths, atherectomy devices, thrombectomy devices, inflation devices and vascular closure devices. MRG also gathers data from Europe, Japan, Asia Pacific, Latin America and the Middle East. Marketrack subscribers receive thousands of data points, including usage (units, average selling price, and revenue), procedure, competitor, and brand information.

For more information visit

Related Content

Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score Percutaneous Transluminal Angioplasty (PTA) Scoring Sheath platform for use in iliac, ilio-femoral, popliteal, infra-popliteal and renal arterial plus synthetic and/or native arteriovenous hemodialysis fistula. This is a new type of scoring balloon technology.
News | Balloon Catheter | June 04, 2020
June 4, 2020 — Transit Scientific announced the U.S.
NC Trek RX Coronary Dilatation Catheter is part of an FDA Class I recall because it may not defalte.
News | Balloon Catheter | February 24, 2020
February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters
Edwards Lifesciences Recalls IntraClude Intra-aortic Occlusion Device
News | Balloon Catheter | July 15, 2019
Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon rupture during...
Gore Molding & Occlusion Balloon for Endovascular Aortic Repair Receives FDA Approval
Technology | Balloon Catheter | August 23, 2018
W. L. Gore & Associates Inc. (Gore) announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Gore...
Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...